Platelet gigantism associated with cholestyramine therapy.
Latger-Cannard
V
V
Vandoeuvre-les-Nancy, France.
Sommelet
D
D
Guerci
B
B
Tréchot
P
P
Lecompte
T
T
D000924:Anticholesteremic Agents / Q000009:adverse effects*; D001791:Blood Platelet Disorders / Q000139:chemically induced* / Q000473:pathology; D002648:Child; D002792:Cholestyramine Resin / Q000009:adverse effects*; D005877:Gigantism / Q000139:chemically induced* / Q000473:pathology; D006801:Humans; D008297:Male
D000924:Anticholesteremic Agents; D002792:Cholestyramine Resin